Quick Answer
Sotera Health Co reported Cash and Equivalents of $344.62 million for fiscal year 2025.
Sotera Health Co Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $344.62M | +24.3% |
| 2024 | $277.24M | -6.5% |
| 2023 | $296.41M | -25.0% |
| 2022 | $395.21M | +269.6% |
| 2021 | $106.92M | +4.4% |
| 2020 | $102.45M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $299.19M | -2.5% | -10.0% |
| June 30, 2025 | $332.44M | +35.1% | +9.2% |
| March 31, 2025 | $304.39M | +16.6% | +9.8% |
| December 31, 2024 | $277.24M | -6.5% | -9.6% |
| September 30, 2024 | $306.74M | +25.2% | +24.6% |
| June 30, 2024 | $246.08M | -6.3% | -5.8% |
| March 31, 2024 | $261.13M | -59.7% | -11.9% |
| December 31, 2023 | $296.41M | -25.0% | +21.0% |
- Sotera Health Co showed an increase of +24.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, Sotera Health Co’s cash and equivalents has grown by 236.4% (from $102.45 million to $344.62 million).
- The most recent figure is from Sotera Health Co’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: